HOME >> BIOLOGY >> NEWS
Vertex Pharmaceuticals/Yale Research Team Uses Gene Knockout Mice To Establish Role Of Caspase-9 In Neuronal Cell Death Pathway

Cambridge, MA, August 7, 1998 -- A team of scientists from Vertex Pharmaceuticals, Yale University School of Medicine, Howard Hughes Medical Institute (HHMI) at Yale University, and Tokyo Metropolitan Institute of Medical Science (TMI) reported results with a gene knockout mouse that establishes a key role for the enzyme Caspase-9 in a specific biochemical pathway that results in neuronal cell death. These findings, published in the August 7, 1998 issue of Cell, suggest that blocking Caspase-9 may be a viable strategy for treating a variety of acute and chronic age-related neurological diseases, including Alzheimer's disease, Parkinson's disease and stroke.

Caspases comprise a family of enzymes that are being evaluated for their role in a number of diseases, based on their involvement in biochemical pathways of inflammation and of apoptosis (also known as programmed cell death or cell suicide). Apoptosis is an essential component of numerous biological processes, including tissue remodeling, immune system regulation and embryonic development. Abnormal activation of apoptosis, however, is implicated in the development and progression of a number of different human diseases, and links between specific caspases and specific diseases are beginning to be established. The publication of the Cell paper is the first report describing the in vivo function of Caspase-9, and suggests apparent tissue-selective activity among the eleven reported human caspases.

"When mitochondria -- the energy factory of cells -- are damaged, Caspase-9 is activated leading to cell death," said Dr. Richard A Flavell, an HHMI Investigator and an author of the study. "In cells lacking Caspase-9, this damage did not give rise to cell death."

"Our results also indicate that Caspase-9 is activated early and is essential for apoptosis in neuronal cells, and that deletion of Caspase-9 does not interfere with embryonic development of other non-neuronal tissues," said Dr. Keisuke Kuida, St
'"/>

Contact: Michael Partridge
partridge@vpharm.com
(617) 577-6108
Vertex Pharmaceuticals
7-Aug-1998


Page: 1 2 3 4

Related biology news :

1. Research Findings Suggest Potent, Broad-Spectrum Antiviral Activity For Vertexs Investigational IMPDH Inhibitor VX-497
2. Phase III Results Suggest Potent Antiviral Activity For Vertex And Glaxo Wellcomes Second-Generation HIV Protease Inhibitor Agenerase TM
3. Vertex Researchers Report Three-Dimensional Atomic Structure Of JNK3 Enzyme; Report In Structure
4. Vertex Pharmaceuticals Researchers Report Three-Dimensional Structure Of Hepatitis C Helicase Enzyme; Report In Structure
5. Researchers determine genetic cause of Timothy syndrome
6. Researchers find color sensitive atomic switch in bacteria
7. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
8. Researchers identify protein promoting vascular tumor growth
9. Researchers devise potent new tools to curb ivory poaching
10. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
11. Researchers ID chlorophyll-regulating gene

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/4/2019)... ... June 04, 2019 , ... Molecular Devices, ... Susan Murphy as the new President of Molecular Devices, replacing Greg Milosevich who ... company, Danaher Corporation. , Since joining Molecular Devices in a scientific engineering role, ...
(Date:6/3/2019)... ... June 03, 2019 , ... Stay on top of current hot topics ... industries. Access to all webinars is free, so be sure to register today to ... Visit http://www.xtalks.com to see our upcoming webinars: , CLINICAL TRIALS , June ...
(Date:5/31/2019)... ... 2019 , ... Join Julie Peacock, Vice President of Product ... June 19, 2019 at 1pm EDT where she will demonstrate how role-based data ... contract research organizations (CROs) can improve collaboration, auditing, document tracking and reporting. , ...
Breaking Biology News(10 mins):
(Date:5/14/2019)... ... May 13, 2019 , ... ... testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries’ is ... redesigned website aims to improve LDA’s ability to communicate directly with the marketplace; ...
(Date:5/4/2019)... ... 03, 2019 , ... Diopsys Inc, the world leader in ... vision test, a new full field electroretinography (ffERG) protocol designed to detect ... Americans will have glaucoma, with black Americans having the highest prevalence rate. This ...
(Date:5/2/2019)... ... May 02, 2019 , ... ... in the greater Boston area. Gone are the days of painful hair transplant ... Robotic Hair Restoration System is the only robotic intelligent solution to offer a ...
(Date:4/16/2019)... , ... April 16, 2019 , ... ... systems, applications, and technology, today announced that Bank South Pacific (BSP), the largest ... RFP process. The bank awarded Fulcrum a contract to deliver a fingerprint-based Know ...
Breaking Biology Technology:
Cached News: